By What Percent Might Altria Raise Its Dividend?
Altria (NYSE:MO) has a history of boosting its dividend for 46 years consecutively, after accounting for the impact of spin-offs. The company’s target dividend payout ratio is ~80% of its adjusted EPS, with a present annualized dividend rate of $2.26 per share. If the dividend stayed at the same rate, it would represent a growth of over 4% for 2016.
See Our Complete Analysis For Altria
However, the company has ordinarily raised its dividend in the second half of the year. This would imply that the investors are in for a dividend improvement, once it is announced. Given the company’s target payout of 80%, we can consider a scenario where the dividends are computed, keeping in mind its annual EPS projection.
During the recent second quarter earnings conference call, the company raised its outlook for the year, saying it expects adjusted earnings of $3.01 to $3.07, up from $3 to $3.05 per share. If we take an average of that for our calculations, an EPS of $3.04 can be used.
This scenario shows a dividend growth of close to 8%. However, if we actually consider the EPS consensus estimates for our calculations, the rate of growth in the dividend payment will actually be much higher. According to Nasdaq, the quarterly EPS projections for the next four quarters (Q3 and Q4 of FY 2016, and Q1 and Q2 of FY 2017) are $0.81, $0.73, $0.78, and $0.88, totaling $3.20. One of the possible reasons for Altria raising its outlook could be the windfall it will receive from the SABMiller- AB InBev deal.
The company is also looking to its smokeless products segment to be a key growth driver in the future, especially since the smoking rates have been on a decline in recent years, leaving only price increases as a way to generate more revenue from the smokeable products division.
Given these factors, we feel the dividend increase by the company will be in the range of 7.6% and 13.3%, (probably in the 8% range of the last few years), which, although may sound large, may not be such a problem, given the increase in the expected pre-tax cash it will receive from the SABMiller buyout, from $2.5 billion to $3 billion.
Have more questions on Altria? Have a look at the links below:
- Altria Q2 Earnings: Marlboro Volumes Fall, But Overall Market Share Remains Flat
- How Will Altria Perform In Q2 2016?
- Is Altria’s Growth Sustainable?
- What Can Lead To A 10% Downside In Altria’s Valuation In The Next Few Years?
- Which Is A Better Dividend Bet – Altria Or Philip Morris?
- Altria’s Stock Still Smoking Hot After The Brexit
- What Will Be Altria’s Revenue And EBITDA Breakdown In 2016?
- What Are Altria’s Strategies For Long-Term Growth?
- How Will Altria Perform In 2016?
- How Will The New FDA Ruling On E-Cigarettes Help Altria?
- What Is The State Of The Vapor Market In The U.S.?
- How Did The Different Segments Of Altria Perform In Q1 2016?
- Impressive Growth In The Smokeable Products Segment Helps Altria Beat Estimates
- How Will Altria Perform In Q1 2016?
- What Are Altria’s Strengths Driving Long-Term Growth?
- What Are Some Obstacles To Altria’s Long-Term Growth?
- How Will Altria’s Revenue And EBITDA Change In The Next 3 Years?
- How Has Altria’s Revenue And EBITDA Composition Changed In The Last 5 Years?
- Altria: Year 2015 In Review
- How Has Altria’s Shipment Volume, By Brand, Changed Over The Past 3 Years?
- How Has Altria’s Retail Share In Smokable Products And Smokeless Products Changed Over The Last Year?
- What is Altria’s Revenue And EBITDA Breakdown?
- What is Altria’s Fundamental Value Based On Expected 2016 Results?
- By What Percentage Did Altria’s Revenue & EBITDA Grow In The Last 5 Years?
- What’s Next For Altria Stock After A 15% Fall In A Year?
- What’s Next For Altria Stock After A 6% Fall In A Month Amid Downbeat Q3?
- Is Boston Scientific A Better Pick Over Altria Stock?
- Will Altria Stock Rebound To Its 2022 Highs?
- Here’s What To Expect From Altria’s Q1
- Should You Buy Altria Stock At $44?
Notes:
Global Large Cap | U.S. Mid & Small Cap | European Large & Mid Cap
More Trefis Research